The Korea Journal of Herbology (대한본초학회지)

The Korea Association of Herbology (대한본초학회)
권호 표지

Inhibitory Effect of Licorice Ethanol Extracts on Cytochrome P450 Drug-Metabolizing Enzymes in Human Liver Microsomes

甘草 에탄올 추출물이 인체 간 Microsome에서 Cytochrome P450 약물대사효소에 대한 억제효과(물 추출물과의 비교를 중심으로)

Park, Jong-Hun;Park, Ji-Yeong;Ju, Yeong-Sung
박종훈;박지영;주영숭

  • Published : 20040000

⟨ Previous Next ⟩

Abstract

Objective: The aim of present study is to evaluate the inhibitory potential of licorice extract on cytochrome P450 (CYP) in human liver microsomes. Methods: Using human liver microsomes, either water or ethanol extract of licorice as an inhibitor was co-incubated with each probe drug representing selective CYP isoform activity. We measured relative metabolic activity in incubation condition compared to that with no extract of licorice using HPLC system. Results: Both water and ethanol extracts of licorice showed inhibitory effect on CYP-catalyzed reactions. CYP2C19 (IC50= 126.7pg/ml) is most potently inhibited by water extract than other tested CYP isoforms (IC50>450pg/ml), but ethanol extract of licorice exhibited potent inhibition on CYP2C8 (IC50= 43.2pg/ml), followed by CYP2C9 (IC50= 72.8pg/ml), and CYP2C9 (IC50= 98.1pg/ml). Additionally, ethanol extract of licorice showed relatively more potent inhibition compared to that of water extract (2.5-14 fold potent). Conclusion: These results indicate that extract of licorice has inhibitory potential on CYP-catalyzed reaction in human liver microsomes, and ethanol extract of licorice showed more potent inhibition than its water extract. The inhibition by licorice on CYP isoforms may cause drug interaction with co-administered drug leading to toxicity or treatment failure.

Keywords

References

  1. 석사학위논문 補氣韓藥材 9種의 起源 및 性狀에 관한 문헌적 연구. 강경식
  2. Pharmacognosy(9th Ed.) Tyler VE;Brady LR;Robbers JE.
  3. The Pharmacology of Chinese herbs.(2nd ed.) Huang KC.
  4. Biochem Pharmacol. v.14 Biochemical study of anti-inflammatory and anti-arthritic properties of glycyrrhetic acid. Tangri KK;Seth PK;Parmar SS;Bhargava KP.
  5. J Commun Dis. v.29 In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus. Badam L.
  6. Nutr Cancer. v.39 Licorice and cancer Wang ZY;Nixon DW.
  7. Pharmacol Res. v.46 Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression. Jeong HG;You HJ;Park SJ;Moon AR;Chung YC;Kang SK;Chun HK.
  8. J Biol Chem. v.266 Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. Porter TD;Coon MJ.
  9. Drug Metab Rev. v.29 Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Rendic S;Di Carlo FJ.
  10. JAMA. v.280 Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. Eisenberg DM;Davis RB;Ettner SL;Appel S;Wilkey S;Van Rompay M;Kessler RC.
  11. JAMA. v.286 Herbal medicines and perioperative care. Ang-Lee MK;Moss J;Yuan CS.
  12. J Pharmacol Exp Ther. v.265 Specificity of substrate and inhibitor probes for human cytochrome P450 1A1 and 1A2. Tassaneeyakul W;Birkett DJ;Veronese ME;McManus ME;Turkey RH;Quattrochi LC;Gelboin HV;Miners JO
  13. J Pharmacol Exp Ther. v.252 Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. Relling MV;Aoyama T;Gonzalez FJ;Meyer UA
  14. Arch Biochem Biophys. v.306 Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation. Wrighton SA;Stevens JC;Becker GW;Vanden Branden M
  15. J Pharmacol Exp Ther. v.276 Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole. Von Moltke LL;Greenblatt DJ;Harmatz JS;Duan SX;Harrel LM;Cotreau-Bibbo MM;Pritchard GA;Wright CE;Shader RI
  16. Br J Clin Pharmacol. v.49 In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6. Ko JW;Desta Z;Soukhova NV;Tracy T;Flockhart DA
  17. Eur J Drug Metab Pharmacokinet. v.23 Human liver microsomal metabolism of paclitaxel and drug interactions. Desai PB;Duan JZ;Zhu YW;Kouzi S
  18. Am J Hosp Pharm v.32 Licorice-induced pseudoaldosteronism Wash LK;Bernard JD.
  19. Prolonged pseudoaldosteronism induced by glycyrrhizin Endocrinol v.26 Takeda R;Morimoto S;Uchida K;Nakai T;Miyamoto M;Hashiba T;Yoshimitsu K;Kim KS;Miwa U.
  20. Hypertension in licorice abuse. A case report. G Ital Cardiol. v.13 Cugini P;Gentile R;Zard A;Rocchi G
  21. Steroids. v.58 Inhibition by glycyrrhetinic acid of rat tissue 11 beta-hydroxysteroid dehydrogenase in vivo. Marandici A;Monder C.
  22. Steroids. v.61 11 beta-Hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects. Edwards CR;Benediktsson R;Lindsay RS;Seckl JR.
  23. Life Sci. v.62 no.2 Effect of licorice and glycyrrhizin on murine liver CYP-dependent monooxygenases. Paolini M;ozzetti L;Sapone A;Cantelli-Forti G.
  24. Phytomedicine. v.7 An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Budzinski JW;Foster BC;Vandenhoek S;Arnason JT.
  25. Drug Metab Dispos. v.30 The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9. Kent UM;Aviram M;Rosenblat M;Hollenberg PF.
  26. Xenobiotica. v.28 Human cytochrome P450s: selectivity and measurement in vivo. Smith DA;Abel SM;Hyland R;Jones BC.